Clinical Trials Browser

Withdrawn × Classical hematology × 1 year × Clear all

NCT06284460 2026-02-13

Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms

Phase 1/2 Withdrawn

Classical hematologyMyeloid

Anemia, Refractory, with Excess of Blasts, Myeloproliferative Disorders

NCT06098755 2026-02-04

The Sequestration of Holistic Stress Management Techniques for Adults

Phase NA Withdrawn

Classical hematologyHead & NeckOther

Brain Injuries, Traumatic, Occupational Stress, Anemia, Anemia, Sickle Cell, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Depression, Escape Reaction, Fatigue, Flatfoot, Hemorrhoids, Hypertension, Hyperthyroidism, Immunologic Deficiency Syndromes, Erectile Dysfunction, Leiomyoma, Lordosis, Masturbation, Migraine Disorders, Priapism, Sickle Cell Trait, Stress Disorders, Post-Traumatic, Sexual Dysfunctions, Psychological, Migraine with Aura

NCT06254742 2025-08-07

A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies

Phase 3 Withdrawn

Classical hematology

Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk

NCT06508827 2025-07-09

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Phase 2 Withdrawn

Classical hematologyDermatologic

Anemia, Melanoma, Anemia, Iron-Deficiency

NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Phase NA Withdrawn

Classical hematologyOther hematologic neoplasm

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms